Trials / Completed
CompletedNCT00399061
Efficacy of Optive Versus Systane Concomitant With Restasis (Cyclosporine A) for the Treatment of Dry Eye Symptoms
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 55 (actual)
- Sponsor
- Innovative Medical · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the efficacy of Optive versus Systane used concomitantly with topical cyclosporine for the treatment of dry eye.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Systane, Optive, Restasis | Systane 30ml (in the eye) instill one drop twice a day in morning and evening Optive 15ml (in the eye) instill one drop twice a day in morning and evening Restasis 0.4ml (in the eye) instill one drop twice a day in morning and evening more frequently if needed |
Timeline
- Start date
- 2006-11-01
- Primary completion
- 2008-09-01
- Completion
- 2008-09-01
- First posted
- 2006-11-14
- Last updated
- 2008-09-25
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00399061. Inclusion in this directory is not an endorsement.